Is there any hard evidence that MK-801 does or does not cause NMDA
receptor up-regulation after chronic administration of this drug? The
available body of literature is rather ambiguous.
Wolfram Schwindt
--
Dr. med. Wolfram Schwindt
Max-Planck-Institut für neurologische Forschung
Gleueler Str. 50
50931 Köln
Tel.: +49-221-4726-0 or -318
Fax.: +49-221-4726-337